Show simple item record

dc.contributor.authorBakare, Olalekan Olanrewaju
dc.contributor.authorGokul, Arun
dc.contributor.authorKeyster, Marshall
dc.date.accessioned2022-09-06T13:56:30Z
dc.date.available2022-09-06T13:56:30Z
dc.date.issued2022
dc.identifier.citationBakare, O. O. et al. (2022). Analytical studies of antimicrobial peptides as diagnostic biomarkers for the detection of bacterial and viral Pneumonia. Bioengineering, 9(7), 305. https://doi.org/10.3390/bioengineering9070305en_US
dc.identifier.issn2306-5354
dc.identifier.urihttps://doi.org/10.3390/bioengineering9070305
dc.identifier.urihttp://hdl.handle.net/10566/7821
dc.description.abstractPneumonia remains one of the leading causes of infectious mortality and significant economic losses among our growing population. The lack of specific biomarkers for correct and timely diagnosis to detect patients’ status is a bane towards initiating a proper treatment plan for the disease; thus, current biomarkers cannot distinguish between pneumonia and other associated conditions such as atherosclerotic plaques and human immunodeficiency virus (HIV). Antimicrobial peptides (AMPs) are potential candidates for detecting numerous illnesses due to their compensatory roles as theranostic molecules. This research sought to generate specific data for parental AMPs to identify viral and bacterial pneumonia pathogens using in silico technology.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.subjectPneumoniaen_US
dc.subjectAntimicrobial peptidesen_US
dc.subjectBacteriaen_US
dc.subjectGlobal healthen_US
dc.subjectVirusesen_US
dc.titleAnalytical studies of antimicrobial peptides as diagnostic biomarkers for the detection of bacterial and viral Pneumoniaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record